X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

期刊標題檢索 J AM SOC NEPHRO 最新評論: How come the scores have dropped so much this year? (2023-02-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY]您好,您是該頁面的第 40456 位訪客。

期刊簡介
期刊名稱JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
LetPub Score
9.1
50 ratings
Rate

Reputation
10.0

Influence
8.5

Speed
8.2

期刊簡稱J AM SOC NEPHROL
ISSN1046-6673
E-ISSN1533-3450
h-index253
CiteScore
CiteScoreSJRSNIPCiteScore Rank
22.403.4092.066
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Transplantation
Q11 / 54
Category: Medicine
Subcategory: Critical Care and Intensive Care Medicine
Q13 / 110
Category: Medicine
Subcategory: Nephrology
Q14 / 81
Category: Medicine
Subcategory: Epidemiology
Q17 / 148

自引率 (2023-2024)3.90%自引率趨勢
掲載範囲
JASN publishes highly competitive original manuscripts, brief reviews, and special articles in areas of basic and clinical science relevant to the broad discipline of nephrology. Subject matter appropriate for JASN includes, but is not restricted to: cell biology; developmental biology; genetics; cell and transport physiology; hemodynamics and vascular regulation; immunology and pathology; pathophysiology of renal disease and progression; mineral metabolism and bone disease; clinical nephrology, epidemiology,
and outcomes; dialysis; and transplantation. The editors encourage only the submission of meritorious research that will communicate important advances in the field of nephrology.
官方網站http://jasn.asnjournals.org/
在線稿件提交https://mc.manuscriptcentral.com/jasn
開放訪問No
出版商American Society of Nephrology
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年0
每年文章數143每年文章數趨勢
黃金OA百分比5.43%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
UROLOGY & NEPHROLOGYSCIEQ16/126
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1046-6673%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews NephrologyH-index: 88

    CiteScore: 39.00
    EUROPEAN UROLOGYH-index: 187

    CiteScore: 43.00
    KIDNEY INTERNATIONALH-index: 250

    CiteScore: 23.30
    Nature Reviews UrologyH-index: 65

    CiteScore: 12.50
    AMERICAN JOURNAL OF KIDNEY DISEASESH-index: 196

    CiteScore: 20.40
    Clinical Journal of the American Society of NephrologyH-index: 128

    CiteScore: 12.20
    JOURNAL OF UROLOGYH-index: 236

    CiteScore: 11.50
    PROSTATE CANCER AND PROSTATIC DISEASESH-index: 56

    CiteScore: 10.00
    NEPHROLOGY DIALYSIS TRANSPLANTATIONH-index: 155

    CiteScore: 10.10
    AMERICAN JOURNAL OF NEPHROLOGYH-index: 75

    CiteScore: 7.50
    學科內最受檢索的期刊 頁面查看次數
    KIDNEY INTERNATIONAL58737
    RENAL FAILURE56045
    JOURNAL OF UROLOGY51786
    BJU INTERNATIONAL49275
    EUROPEAN UROLOGY44559
    INTERNATIONAL UROLOGY AND NEPHROLOGY42992
    UROLOGY42053
    ASIAN JOURNAL OF ANDROLOGY39279
    PROSTATE38621
    NEPHROLOGY DIALYSIS TRANSPLANTATION38467
  •  

    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY] 的評論撰寫評論
作者: 风啸以柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-23 10:33:16 評論於
How come the scores have dropped so much this year?
(0) 讚! | 风啸以柳

作者: 邻家忆夏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-06 17:03:13 評論於
The instructions of authors in the author resources have formatting requirements. Reviews should have the following elements in order: title page, abstract, integrated discussion, acknowledgments, disclosures, funding, references, figure legend, and figure(s) or table(s
(0) 讚! | 邻家忆夏

作者: 邻家忆夏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-27 12:35:55 評論於
It shouldn't be accepted
(0) 讚! | 邻家忆夏

作者: 易筋含烟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-10 17:33:37 評論於
Is there any specific format requirement for the submission of review articles? I didn't see any requirements for reviews on the official website
(0) 讚! | 易筋含烟

作者: 雾都己酉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-15 09:58:36 評論於
Awesome!
(0) 讚! | 雾都己酉

作者: 是你的艳蕾呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-08 20:45:06 評論於
This magazine requires signing a copyright agreement before even submitting the article. Shouldn't it be signed after acceptance?
(0) 讚! | 是你的艳蕾呀

作者: 凌霄秋灵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-21 23:10:53 評論於
When registering for a JASN account, it prompts for a verification code, but the website does not display any verification. What should I do?
(0) 讚! | 凌霄秋灵

作者: 凌霄秋灵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-09 21:17:52 評論於
Do we need a fluorescence curve for QPCR?
(0) 讚! | 凌霄秋灵

作者: 岭南念真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-28 11:12:09 評論於
May I submit a case?
(0) 讚! | 岭南念真

作者: 邻家忆夏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-19 21:04:47 評論於
Please send the agreed manuscript to us, and we will usually decide whether to send it for review within a week. If your research group needs the article to be published urgently, we can even make the decision to send it for review on the next day
(0) 讚! | 邻家忆夏

作者: 邻家忆夏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-19 08:53:55 評論於
Agreeing to something generally means that you are interested in the topic. The likelihood is quite high, with the main determining factor being your writing level
(0) 讚! | 邻家忆夏

作者: Gail Acheson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-07 12:35:40 評論於
Hello, I would like to inquire about how many days it will take for a manuscript to enter the "under review" stage with the editor. I have previously received an invitation to submit the paper and the editor agreed to consider it for publication. What are the chances of it being rejected in this scenario?
(0) 讚! | Gail Acheson

作者: suleyman


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2022-01-12 22:35:56 評論於
Translated text: "Reviewed a comprehensive review as a free submission. The first review was relatively fast, exactly one month. The questions raised by the reviewers significantly improved the quality of the manuscript. After making revisions for a month, it was resubmitted and accepted after more than 20 days."
(0) 讚! | suleyman

作者: 邻家忆夏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-05 22:39:53 評論於
Review Speed: 1.0 | Submission Hit Rate: 50.0 | Page Fee: 2800.0
Experience Sharing: Successfully submitted a free-review overview article. The first review was quite fast, exactly one month. The questions raised by the reviewers helped to improve the quality of the manuscript. Returned for revision after one month, and accepted after more than 20 days
(0) 讚! | 邻家忆夏

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:17:42 評論於
Currently ORCID is optional, not mandatory. It is important to note that most publishers (including Elsevier, Wiley, Nature, Thomson Reuters) now require all researchers associated with their publications to use an ORCID iD.
If an article is published without providing an ORCID iD, how can it be added?
ORCID stands for Open Researcher and Contributor ID. The ORCID iD is a unique and persistent academic identity for authors, distinguishing them from other researchers and recording all of their relevant research activities. It is necessary to log into each author's account, then link it in the account information modification section
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:29:58 評論於
ORCID is an open researcher and contributor identifier (Researcher and Contributor ID), and is a non-profit organization. The ORCID ID is a unique and persistent academic identity for authors, distinguishing them from other researchers and recording all their relevant research activities.

Researcher can register for an ORCID ID for free at https://orcid.org/signin by providing their name, email, and setting a password
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 22:14:09 評論於
What is ORCID ID? How can I register?
(0) 讚! | 八坂篷蔚

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 11:36:21 評論於
Is it necessary to provide the ORCID ID of each author when submitting a manuscript?
(0) 讚! | 北国博达

作者: 采梦可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-15 11:43:47 評論於
Can WB strips be trimmed or must they be fully coated?
(0) 讚! | 采梦可爱吗

作者: Oliver Jerry


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-10-25 10:12:35 評論於
Amazing, amazing
(0) 讚! | Oliver Jerry

作者: 北海初柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-12 19:46:47 評論於
One as the first author and one as the corresponding author were accepted by two journals. It was tough for me personally as the amount of data is large, and the reviewers raised very professional and challenging questions on the articles, pinpointing its weaknesses. The process of publishing these articles was long; it took more than a year for each to go online
(0) 讚! | 北海初柳

作者: Anonymous


領域: 医药科学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2016-08-19 11:03:41 評論於
It took a long time from submission, revisions, reception, and being published online to receiving a paper version. It is very hard to get accepted by this journal.

(0) 讚! | Anonymous

作者: 巴蜀景同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-08-19 10:32:47 評論於
Review speed: 6.0
Experience sharing: Being the co-first author of a paper, it took almost half a year from submission, major revision, acceptance, online publication to receiving the hard copy. It was really tough
(0) 讚! | 巴蜀景同

作者: Vincent Gracie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-10-25 21:56:05 評論於
It took nearly half a year from submitting, revising, being accepted, going online to receiving the print version for this shared first-authored paper, which was torturous
(0) 讚! | Vincent Gracie

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-03-22 19:42:11 評論於
Review speed: 2.0 | Submission hit rate: 25.0
Experience sharing: The above is nonsense, nonsense
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*